Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ann Dermatol Venereol ; 139(5): 346-9, 2012 May.
Artigo em Francês | MEDLINE | ID: mdl-22578337

RESUMO

BACKGROUND: The data concerning changes in the characteristics of hypertensive leg ulcers (HLU) were taken from open studies in a small patient cohort. The aim of this study was to describe the epidemiological characteristics and to identify prognostic factors for healing in a prospective cohort of 59 patients presenting HLU. PATIENTS AND METHODS: The cohort comprised patients included in a randomized, double-blind, controlled study published elsewhere; the patients were receiving becaplermin gel (Regranex(®)) or Duoderm Hydrogel™ once daily for eight weeks for the most recent wound. Total follow-up was 12 weeks. RESULTS: The epidemiological analysis was performed for 59 consecutive patients randomized in 17 dermatology departments. Mean patient age was 74.5 ± 9 years and 61% were female. Mean wound duration was 11.1 ± 9 weeks and median wound area was 16 cm(2) (q1; q3: 8; 25.5). Among, 94.9% of patients had hypertension and 39.7% were diabetic. A homolateral peripheral pulse was present in 91.5% of patients. At the end of follow-up, complete wound healing was obtained in 30.5% of the patients. In univariate analysis, neither the foregoing criteria nor the treatment group were significantly associated with healing during the study. CONCLUSION: This study confirms female predominance, old age, prevalence of diabetes and delay in the diagnosis of HLU. The prognosis for healing does not appear to be dependent on wound duration, wound area or the presence of moderate peripheral arterial disease, doubtless because this condition progresses by episodes of flare-up and under specific conditions.


Assuntos
Indutores da Angiogênese/uso terapêutico , Cicatriz , Úlcera da Perna/tratamento farmacológico , Úlcera da Perna/epidemiologia , Proteínas Proto-Oncogênicas c-sis/uso terapêutico , Idoso , Becaplermina , Método Duplo-Cego , Feminino , Humanos , Hipertensão/complicações , Úlcera da Perna/diagnóstico , Úlcera da Perna/etiologia , Masculino , Prognóstico , Estudos Prospectivos , Indução de Remissão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA